FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression

The FDA has approved a fast-acting treatment to help people whose depression hasn’t responded to other treatments. The nasal spray, derived from ketamine, eases symptoms of depression, anxiety, and suicidal thinking.

FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression

Three decades after Prozac arrived, consumers are getting a new kind of antidepressant. The medicine is based on the anesthetic ketamine, which has been used illicitly as a party drug.

Source